Artelo Biosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

LEASE (Tables)

LEASE (Tables)

9 Months Ended

Sep. 30, 2023

Schedule of operating lease right-of use assets and lease information

		Nine months ended
		September 30,
		2023				2022

Lease cost
Operating lease cost		$	30			$	30

Other information
Cash paid for operating cash flows from operating leases		$	32			$	34
Right-of-use assets obtained in exchange for new operating lease liability		$	-			$	20

Weighted-average remaining lease term — operating leases (year)			0.92				1.81
Weighted-average discount rate — operating leases			3.00	%			2.98	%

Schedule of operating lease liabilities future minimum lease payments

		Total
Year Ended December 31,
2023 - Remaining 3 months		$	9
2024			23
Thereafter			-
			32
Less: Imputed interest			-
Operating lease liabilities			32

Operating lease liability - current			32
Operating lease liability - non-current		$	-